JP2012144537A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012144537A5 JP2012144537A5 JP2012040002A JP2012040002A JP2012144537A5 JP 2012144537 A5 JP2012144537 A5 JP 2012144537A5 JP 2012040002 A JP2012040002 A JP 2012040002A JP 2012040002 A JP2012040002 A JP 2012040002A JP 2012144537 A5 JP2012144537 A5 JP 2012144537A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharmaceutically acceptable
- compound
- compounds
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000001475 halogen functional group Chemical group 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 150000005840 aryl radicals Chemical class 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003509 tertiary alcohols Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61129904P | 2004-09-21 | 2004-09-21 | |
| US60/611299 | 2004-09-21 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004315009A Division JP4976649B2 (ja) | 2004-09-21 | 2004-10-29 | 化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014104217A Division JP5816868B2 (ja) | 2004-09-21 | 2014-05-20 | 化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012144537A JP2012144537A (ja) | 2012-08-02 |
| JP2012144537A5 true JP2012144537A5 (OSRAM) | 2013-03-28 |
Family
ID=34956540
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004315009A Expired - Fee Related JP4976649B2 (ja) | 2004-09-21 | 2004-10-29 | 化合物 |
| JP2012040002A Pending JP2012144537A (ja) | 2004-09-21 | 2012-02-27 | 化合物 |
| JP2014104217A Expired - Fee Related JP5816868B2 (ja) | 2004-09-21 | 2014-05-20 | 化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004315009A Expired - Fee Related JP4976649B2 (ja) | 2004-09-21 | 2004-10-29 | 化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014104217A Expired - Fee Related JP5816868B2 (ja) | 2004-09-21 | 2014-05-20 | 化合物 |
Country Status (2)
| Country | Link |
|---|---|
| JP (3) | JP4976649B2 (OSRAM) |
| CN (1) | CN101094844B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE532777T1 (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie |
| JP4976649B2 (ja) * | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ，インク． | 化合物 |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| US9663484B2 (en) | 2010-11-01 | 2017-05-30 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
| CN103224481A (zh) * | 2013-05-20 | 2013-07-31 | 黑龙江大学 | 一种去氢雌马酚的制备方法 |
| SG11201604490SA (en) * | 2014-02-07 | 2016-07-28 | Novogen ltd | Functionalised benzopyran compounds and use thereof |
| JP6218680B2 (ja) * | 2014-06-11 | 2017-10-25 | 三菱電機株式会社 | ネットワーク解析支援装置、ネットワーク解析支援方法、および、プログラム |
| CN107427003B (zh) | 2015-02-02 | 2023-01-31 | 梅制药公司 | 联合治疗 |
| CN108409701B (zh) * | 2017-02-10 | 2020-09-25 | 山东康迈祺生物科技有限公司 | 一种二氢大豆苷元的制备方法 |
| CN112920173A (zh) * | 2021-01-25 | 2021-06-08 | 江苏师范大学 | 一种手性苯并二氢吡喃化合物及其合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5883118A (en) * | 1996-01-11 | 1999-03-16 | Nova Nordisk A/S | Prostatic carcinoma |
| ATE229519T1 (de) * | 1996-10-28 | 2002-12-15 | Novo Nordisk As | Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen |
| IL129623A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| KR20000001793A (ko) * | 1998-06-13 | 2000-01-15 | 이경하 | 신규한 벤조피란 또는 티오벤조피란 유도체 |
| NZ527144A (en) * | 2001-01-24 | 2005-03-24 | Chiesi Farmaceutici S | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| JP4976649B2 (ja) * | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ，インク． | 化合物 |
-
2004
- 2004-10-29 JP JP2004315009A patent/JP4976649B2/ja not_active Expired - Fee Related
-
2005
- 2005-09-21 CN CN2005800380156A patent/CN101094844B/zh not_active Expired - Fee Related
-
2012
- 2012-02-27 JP JP2012040002A patent/JP2012144537A/ja active Pending
-
2014
- 2014-05-20 JP JP2014104217A patent/JP5816868B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012144537A5 (OSRAM) | ||
| JP2015537020A5 (OSRAM) | ||
| JP2009542613A5 (OSRAM) | ||
| WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
| RU2015107803A (ru) | Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания | |
| JP2013522229A5 (OSRAM) | ||
| CA2637765A1 (en) | Benzamide and heteroarene derivatives | |
| JP2013519645A5 (OSRAM) | ||
| JP2013545730A5 (OSRAM) | ||
| JP2017531038A5 (OSRAM) | ||
| JP2017531619A5 (OSRAM) | ||
| NZ593712A (en) | Intermediates for synthesising nucleoside aryl phosphoramidates | |
| JP2011529071A5 (OSRAM) | ||
| JP2012506872A5 (OSRAM) | ||
| AU2020319058A1 (en) | Macrocyclic compounds as sting agonists and methods and uses thereof | |
| JP2013519653A5 (OSRAM) | ||
| MX2010007374A (es) | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. | |
| JP2011523952A5 (OSRAM) | ||
| JP2014519488A5 (OSRAM) | ||
| JP2011505356A5 (OSRAM) | ||
| JP2011507896A5 (OSRAM) | ||
| RU2016122731A (ru) | Функционализированные и замещенные индолы в качестве противораковых агентов | |
| JP2013532729A5 (OSRAM) | ||
| EP2968226B1 (en) | Oxprenolol compositions for treating cancer | |
| JP2017533964A5 (OSRAM) |